Conference on Retroviruses and Opportunistic Infections (CROI)

Healio brings you the highlights from the Conference on Retroviruses and Opportunistic Infections (CROI). Refer back to this page often for the latest news from CROI, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

Infectious Disease News prepares for CROI 2018

March 3, 2018
BOSTON — Infectious Disease News and will be onsite at the annual Conference on Retroviruses and Opportunistic Infections, or…
Meeting News

Ibalizumab shows promise in phase 3 trial, via intramuscular administration

March 3, 2017
SEATTLE — Researchers at the Conference on Retroviruses and Opportunistic Infections presented 24-week data of a phase 3 trial that showed…
Meeting News

Nanomedicine provides HIV treatment alternative

March 1, 2017
The results of two trials, which examined the use of nanotechnology to improve drug therapies for HIV patients, found that a new nanomedicine method…
Meeting NewsPerspective

Oral PrEP protective in women with bacterial vaginosis

February 27, 2017
Oral pre-exposure prophylaxis, or PrEP, for HIV prevention has a similar efficacy in women with “abnormal” vs. “normal”…

Top research from CROI highlights new discoveries in HIV, Zika, TB

February 24, 2017
As a service to its readers, Healio Internal Medicine presents the top five news articles from the 2017 Conference on Retroviruses and Opportunistic…
Meeting NewsPerspective

Researchers explore link between substance abuse and HIV

February 23, 2017
SEATTLE — Several studies presented at CROI 2017 explored the link between substance abuse and HIV, with researchers noting opportunities to…
Meeting News

Phase 3 data find doravirine safe, effective for HIV-1 treatment

February 22, 2017
Merck recently announced the results of a phase 3 clinical trial that found doravirine, an investigational non-nucleoside reverse transcriptase…
Meeting News

Challenges remain in progressing PrEP interest to uptake among young black MSM

February 21, 2017
SEATTLE —Despite a high level of interest in pre-exposure prophylaxis, or PrEP, among young black men who have sex with men, researchers…
Meeting News

Smoking cessation reduces risk of cancers in people with HIV; lung cancer most stubborn

February 20, 2017
SEATTLE — Just 1 year after quitting smoking, people with HIV face roughly the same risk of acquiring most cancers as those with the virus who…
Meeting News

Increased treatment of MSM leads to decrease in acute HCV in the Netherlands

February 20, 2017
SEATTLE — Incidence rates of acute hepatitis C virus are expected to decrease substantially over the coming years in the Netherlands, according…